Cardiva VASCADE MVP VVCS 6-12F: payments to doctors
Payments that named Cardiva VASCADE MVP VVCS 6-12F as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 5,642
- Transactions
- 15,099
- Average per transaction
- $95
The per-transaction average — $95 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,642 providers the average total is $256, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Cardiva Medical, Inc. | $1,429,485 | 99.1% |
| Haemonetics Corporation | $12,275 | 0.9% |